ELV

ELV

USD

Elevance Health Inc. Common Stock

$316.620+6.160 (1.984%)

Reaalajas hind

Healthcare
Healthcare Plans
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$310.460

Kõrge

$318.790

Madal

$310.000

Maht

0.89M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

70.4B

Tööstusharu

Healthcare Plans

Riik

United States

Kauplemisstatistika

Keskmine maht

1.99M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $273.71Praegune $316.620Kõrge $458.75

Seotud uudised

Analyst Upgrades

Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400

Mizuho analyst Ann Hynes maintains Elevance Health with a Outperform and lowers the price target from $420 to $400.

Vaata rohkem
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400
Analyst Upgrades

JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394

JP Morgan analyst Lisa Gill maintains Elevance Health with a Overweight and raises the price target from $384 to $394.

Vaata rohkem
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394
Analyst Upgrades

TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380

TD Cowen analyst Ryan Langston maintains Elevance Health with a Buy and raises the price target from $330 to $380.

Vaata rohkem
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380
Analyst Upgrades

Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403

Wells Fargo analyst Stephen Baxter maintains Elevance Health with a Overweight and lowers the price target from $412 to $403.

Vaata rohkem
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403
Reuters

Elevance beats profit estimates as health insurer keeps costs in check

Elevance Health on Tuesday beat Wall Street estimates for third-quarter profit as the health insurer managed to keep medical costs in check, sending its shares 3% higher in premarket trading.

Vaata rohkem
Elevance beats profit estimates as health insurer keeps costs in check
Analyst Upgrades

Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $359

Morgan Stanley analyst Erin Wright maintains Elevance Health with a Equal-Weight and raises the price target from $316 to $359.

Analyst Upgrades

Goldman Sachs Initiates Coverage On Elevance Health with Neutral Rating, Announces Price Target of $343

Goldman Sachs analyst Scott Fidel initiates coverage on Elevance Health with a Neutral rating and announces Price Target of $343.

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.